Study of the Immunogenicity and Efficacy of HBsAg Vaccine in combination with standard antiviral therapy in patients who have been treated with HB110E Hepatitis B DNA vaccine
Latest Information Update: 17 Jun 2014
Price :
$35 *
At a glance
- Drugs GX 110 (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Pharmacodynamics
- Sponsors Genexine
- 03 Jan 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov. record
- 20 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 May 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000713)